FDG-PET/CT in the Evaluation of Patients With Suspected Cholecystitis

• Status: Completed
• Trial end date: 2010-07-01
• Target enrollment: 0
• Participant gender: All

Summary

This is a pilot study to investigate the ability of fluorodeoxyglucose-positron emission tomography (FDG-PET) and Positron emission tomography-computed tomography (PET/CT) as a direct method of detecting infection and/or inflammation of the gallbladder.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Alan D. Waxman, M.D.; Cedars-Sinai Medical Center
• Treatments: Fluorodeoxyglucose F18; Radiopharmaceuticals

Criteria

Inclusion Criteria:

• known or high suspicion of cholecystitis

• highly likely to undergo cholecystectomy

• positive HIDA study

• age >18 years old

• provide written informed consent

Exclusion Criteria:

• highly unlikely to proceed to surgery or biopsy

• received an investigational drug within the past 30 days

• pregnant or lactating

• decline to provide written informed consent